Pierre Triozzi

4PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 12, 2024
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma.

Rhonda L Bitting, Janet A Tooze, Michael Goodman

|May 18, 2023
Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer.

Ryan T Hughes, Rediet R Gebeyehu, John Mason Kalada

|Nov 03, 2018
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.

Alexandra Thomas, Eric D Routh, Ashok Pullikuth

|Aug 28, 2016
Expression of natural killer cell regulatory microRNA by uveal melanoma cancer stem cells.

Powrnima Joshi, Mitra Kooshki, Wayne Aldrich

Pageof 1